TriSalus Life Sciences has recently unveiled a groundbreaking study highlighting the remarkable effectiveness of the TriNav device in treating patients...

Amarin has announced plans to repurchase up to $50 million worth of shares by the end of Q2 2024, pending...

Colleen Kusy, an analyst at Baird, has decided to keep a Neutral rating on Mersana Therapeutics (NASDAQ:MRSN) but has increased...

Endava (NYSE:DAVA) announced its Q2 FY2024 adjusted earnings of $0.37 per share on February 29, 2024, exceeding the analyst consensus...

The Boston Beer Company, Inc. (NYSE:SAM) faced a significant setback on February 29, 2024, as its stock value took a...

EMCOR Group is experiencing a surge in stock prices after surpassing expectations in its Q4 financial results and providing guidance...

On February 29, 2024, JP Morgan analyst Philip Cusick reaffirmed his positive outlook on American Tower (NYSE: AMT) with an...

uniQure's Q4 earnings report for February 28, 2024, revealed some key points worth noting. Here's a breakdown of the highlights:...

RBC Capital Analyst Elvira Scotto has once again affirmed an Outperform rating on Archrock (NYSE: AROC) and has raised the...

On February 28, 2024, Puneet Jain, an analyst at JP Morgan, reiterated a Neutral rating for Perficient (NASDAQ: PRFT) while...